Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · IEX Real-Time Price · USD
5.84
+0.11 (1.92%)
At close: Jul 19, 2024, 4:00 PM
5.79
-0.05 (-0.86%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 13.17, with a low estimate of 5.00 and a high estimate of 19. The average target predicts an increase of 125.51% from the current stock price of 5.84.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for WVE stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 2 | 2 | 2 | 3 | 4 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +156.85% | Jun 26, 2024 |
| Mizuho | Mizuho | Buy Reiterates $19 | Buy | Reiterates | $19 | +225.34% | Jun 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $11 | Buy | Initiates | $11 | +88.36% | May 15, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +191.10% | Apr 1, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $10 → $19 | Strong Buy | Maintains | $10 → $19 | +225.34% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
68.56M
from 113.31M
Decreased by -39.49%
Revenue Next Year
51.44M
from 68.56M
Decreased by -24.98%
EPS This Year
-0.92
from -0.54
EPS Next Year
-0.92
from -0.92
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.0M | 92.3M | 160.6M | 279.3M | 525.0M |
| Avg | 68.6M | 51.4M | 89.6M | 210.2M | 323.5M |
| Low | 33.4M | 5.9M | 34.3M | 92.0M | 93.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -7.3% | 34.6% | 212.2% | 211.6% | 149.8% |
| Avg | -39.5% | -25.0% | 74.3% | 134.4% | 53.9% |
| Low | -70.5% | -91.4% | -33.3% | 2.6% | -55.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.70 | -0.79 | -0.21 | 0.44 | 0.87 |
| Avg | -0.92 | -0.92 | -0.76 | -0.19 | 0.21 |
| Low | -1.10 | -1.23 | -1.15 | -0.93 | -0.97 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.